Enfusion Inc (NYSE: ENFN) has experienced a rise in its stock price by 1.96 compared to its previous closing price of 9.69. However, the company has seen a gain of 6.24% in its stock price over the last five trading days. seekingalpha.com reported 2024-11-04 that Enfusion, Inc. (NYSE:ENFN ) Q3 2024 Earnings Conference Call November 4, 2024 8:30 AM ET Company Participants Bill Wright – Head, IR Oleg Movchan – Chief Executive Officer Bradley Herring – Chief Financial Officer Neal Pawar – Chief Operating Officer Conference Call Participants Michael Infante – Morgan Stanley Dylan Becker – William Blair Parker Lane – Stifel Kevin McVeigh – UBS Elise Kenner – JP Morgan Gabriela Borges – Goldman Sachs Koji Ikeda – Bank of America Crispin Love – Piper Sandler Operator Good morning, ladies and gentlemen. Thank you for standing by.
Is It Worth Investing in Enfusion Inc (NYSE: ENFN) Right Now?
The price-to-earnings ratio for Enfusion Inc (NYSE: ENFN) is above average at 377.10x, Company’s 36-month beta value is 0.96.Analysts have differing opinions on the stock, with 2 analysts rating it as a “buy,” 2 as “overweight,” 3 as “hold,” and 3 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for ENFN is 50.76M, and currently, short sellers hold a 2.32% ratio of that floaft. The average trading volume of ENFN on November 15, 2024 was 381.22K shares.
ENFN’s Market Performance
The stock of Enfusion Inc (ENFN) has seen a 6.24% increase in the past week, with a 11.01% rise in the past month, and a 22.28% gain in the past quarter. The volatility ratio for the week is 3.26%, and the volatility levels for the past 30 days are at 3.21% for ENFN.. The simple moving average for the past 20 days is 7.85% for ENFN’s stock, with a 10.99% simple moving average for the past 200 days.
Analysts’ Opinion of ENFN
Many brokerage firms have already submitted their reports for ENFN stocks, with Morgan Stanley repeating the rating for ENFN by listing it as a “Overweight.” The predicted price for ENFN in the upcoming period, according to Morgan Stanley is $11 based on the research report published on May 10, 2024 of the current year 2024.
Goldman, on the other hand, stated in their research note that they expect to see ENFN reach a price target of $8, previously predicting the price at $9. The rating they have provided for ENFN stocks is “Sell” according to the report published on February 28th, 2024.
JP Morgan gave a rating of “Underweight” to ENFN, setting the target price at $9 in the report published on January 30th of the current year.
ENFN Trading at 10.21% from the 50-Day Moving Average
After a stumble in the market that brought ENFN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -5.45% of loss for the given period.
Volatility was left at 3.21%, however, over the last 30 days, the volatility rate increased by 3.26%, as shares surge +12.15% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +21.98% upper at present.
During the last 5 trading sessions, ENFN rose by +6.24%, which changed the moving average for the period of 200-days by +25.06% in comparison to the 20-day moving average, which settled at $9.16. In addition, Enfusion Inc saw 1.86% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ENFN starting from Campobasso Matthew, who sale 674 shares at the price of $8.95 back on Oct 22 ’24. After this action, Campobasso Matthew now owns 53,627 shares of Enfusion Inc, valued at $6,032 using the latest closing price.
Campobasso Matthew, the Officer of Enfusion Inc, proposed sale 674 shares at $8.95 during a trade that took place back on Oct 22 ’24, which means that Campobasso Matthew is holding shares at $6,031 based on the most recent closing price.
Stock Fundamentals for ENFN
Current profitability levels for the company are sitting at:
- 0.03 for the present operating margin
- 0.67 for the gross margin
The net margin for Enfusion Inc stands at 0.02. The total capital return value is set at 0.06. Equity return is now at value 5.54, with 2.82 for asset returns.
Based on Enfusion Inc (ENFN), the company’s capital structure generated 0.08 points at debt to capital in total, while cash flow to debt ratio is standing at 5.13. The debt to equity ratio resting at 0.08. The interest coverage ratio of the stock is 22.13.
Currently, EBITDA for the company is 11.95 million with net debt to EBITDA at -1.53. When we switch over and look at the enterprise to sales, we see a ratio of 4.64. The receivables turnover for the company is 6.07for trailing twelve months and the total asset turnover is 1.45. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.62.
Conclusion
In a nutshell, Enfusion Inc (ENFN) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
